Nektar Therapeutics (NKTR)

81.89 -1.48 (-1.78%) USD  |  NASDAQ  |  May 08, 16:00
80.51 -1.38 (-1.69%) After-Hours: 20:00
More

Nektar Therapeutics Total Long Term Assets (Quarterly)

Total Long Term Assets (Quarterly) Chart

View Total Long Term Assets (Quarterly) for NKTR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Assets (Quarterly) Range, Past 5 Years

View Total Long Term Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Assets (Quarterly) Benchmarks

View Total Long Term Assets (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Aquestive Therapeutics, Inc. Upgrade
Boston Scientific Corp. Upgrade
Esperion Therapeutics, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade